Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection-Reference-Cited by-同舟云学术

Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection

Published:2022-08-20 Issue:5 Volume:112 Page:1120-1129
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Miano Todd A.¹²,Wang Lei³,Leonard Charles E.¹²⁴^ORCID,Brensinger Colleen M.¹²,Acton Emily K.¹²^ORCID,Dawwas Ghadeer K.¹²^ORCID,Bilker Warren B.¹²⁵^ORCID,Soprano Samantha E.¹²,Nguyen Thanh Phuong Pham¹⁶^ORCID,Woody George⁵,Yu Elmer⁵,Neuman Mark⁷,Li Lang³,Hennessy Sean¹²³⁸^ORCID

Affiliation:

1. Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics University of Pennsylvania Philadelphia Pennsylvania USA

2. Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Biomedical Informatics, College of Medicine The Ohio State University Columbus Ohio USA

4. Leonard Davis Institute of Health Economics University of Pennsylvania Philadelphia Pennsylvania USA

5. Department of Psychiatry, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

6. Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, Department of Neurology, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

7. Department of Anesthesiology and Critical Care, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

8. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2717

Reference51 articles.

1. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020.Focused Update. Accessed March 13 2021.

2. Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US).Facing addiction in America: The surgeon general's report on alcohol drugs and health. Washington (DC): US Department of Health and Human Services (2016). Accessed May 22 2021.

3. Methadone in Pain Management: A Systematic Review

4. Benefit-Risk Analysis of Buprenorphine for Pain Management

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racialized and beneficiary inequities in medication to treat opioid use disorder receipt within the US Military Health System;Drug and Alcohol Dependence;2023-12

2. Cytochrome P450-2D6 activity in people with codeine use disorder;The Pharmacogenomics Journal;2023-11

3. Management of Critically Ill Patients Receiving Medications for Opioid Use Disorder;CHEST;2023-10

4. Non‐fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records;Addiction;2023-08-03